Natural history of liver fibrosis progression in patients with chronic hepatitis C

Lancet

Volumn 349, Issue 9055, 1997, Pages 825-832

  Poynard, Thierry ^a   Bedossa, Pierre ^b   Opolon, Pierre ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGING; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; DISEASE COURSE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SEX DIFFERENCE;

EID: 0030933395     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07642-8     Document Type: Article

References (23)

1. Alter MJ. The epidemiology of hepatitis C in the west. Semin Liver Dis 1995; 15: 5-14.
2. Tong MJ, El-Farra NS, Reikes AR, et al. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-66.
3. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993; 105: 274-78.
4. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-19.
5. Dusheiko GM, Roberts JA. Treatment of chronic type B and C hepatitis with interferon alfa: an economic model. Hepatology 1995; 23: 1863-73.
6. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpoder JJ, Alter H. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 14: 969-74.
7. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T. Natural course of chronic hepatitis C. Am J Gastroenterol 1993; 88: 240-43.
8. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion non-A non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibodies to hepatitis C virus. Hepatology 1990; 12: 671-75.
9. Kobayashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23: 695-99.
10. Delladetsima JK, Rassidakis G, Tassopoulos NC, Papatheodoridis GV, Smyrnoff T, Vafiadis I. Histopathology of chronic hepatitis C in relation to epidemic logical factors. J Hepatol 1996; 24: 27-32.
11. Tremolada F, Casarin C, Alberti A, et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992; 16: 273-81.
12. Yano M, Kumada H, Kage M, et al. The long term pathological evolution of chronic hepatitis C. Hepatology 1996; 23: 1334-40.
13. The METAVIR Cooperative Group. Inter- and intra-ob server variation in the assessment of liver biopsy of chronic hepatitis C. Hepatology 1994; 20: 15-20.
14. Bedossa P, Poynard T, for the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-93.
15. Poynard T, Leroy V, Cohard M, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996; 24: 778-89.
16. Camps J, Castilla A, Ruiz J, Civeira MP, Prieto J. Randomised trial of lymphoblastoid alpha interferon in chronic hepatitis C: effects on inflammation, fibrogenesis and viremia. J Hepatol 1993; 17: 390-96.
17. Gomez-Rubio M, Porres JC, Castillo I, Quiroga JA, Moreno A, Carreno V. Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha interferon in comparison with a control group. J Hepatol 1990; 11 (suppl 1): S63-S67.
18. Saez-Royuela F, Porres JC, Moreno A, Castillo I, Martinez G, Galliana F. High doses of recombinant alpha interferon or gamma interferon for chronic hepatitis C: a randomized controlled trial. Hepatology 1991; 13: 327-31.
19. Poynard T, Bedossa P, Chevallier M, et al, and the Multicenter Study Group. A randomized trial of three a 2b interferon regimens for long term treatment of patients with chronic non-A non-B hepatitis. N Engl J Med 1995; 332: 1457-62.
20. Observatoire National de l'Hepatite C Groupe OBSVIRC. Bilan initial. Association Françoise pour l'Etude du Foie, Lyon 1994. Gastroenterol Clin Biol 1995, 19: 81 (abstr).
21. Koff RS, Seef LB. Economic modeling of treatment in chronic hepatitis B and chronic hepatitis C: promises and limitations. Hepatology 1995; 23: 1880-82.
22. Genesca J, Esteban JI, Alter H. Blood-borne non-A, non-B hepatitis: hepatitis C. Semin Liver Dis 1991; 11: 147-64.
23. Crowe J, Doyle C, Fielding JF, et al. Presentation of hepatitis C in a unique uniform chort 17 years from inoculation. Gastroenterology 1995; 108: A1054.